ClinicalTrials.gg
Not yet recruitingNCT07839962Updated Sep 24, 2026

The Effects of Innatal Yoga Practices on Pain, Comfort, and Satisfaction in Primiparous Women

An interventional study of innatal yoga group in Primiparous Pregnant Women, Yoga and Labor Pains, sponsored by Handan ASATEKİN. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Handan ASATEKİN · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
74
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The aim of this study is to examine the effects of prenatal yoga practices on labor pain, comfort level during labor, and overall birth satisfaction in primiparous pregnant women in Turkey. This study, which will be conducted using a randomized controlled trial design, aims to measure both the physical contribution of prenatal yoga practice to the birthing process and its effects on psychological well-being and satisfaction, thereby providing evidence-based recommendations to improve the quality of childbirth services.

Read the detailed description

Childbirth is a significant turning point in a woman's life cycle, both physiologically and psychologically. For primiparous women, especially first-time mothers, this process can be filled with intense pain, uncertainty, anxiety, and stress. Research shows that 60% to 80% of women worldwide experience anxiety and fear during childbirth (Bharati, Pokhrel \& Bhandari, 2024). A study conducted in Turkey found that 66.3% of pregnant women experienced high levels of fear related to labor pains. Fear of childbirth is not only a psychological experience but can also negatively impact the physiological functioning of the birthing process. Intense fear of childbirth can lead to prolonged labor, an increase in the preference for cesarean sections, and the development of problems such as postpartum depression or post-traumatic stress disorder. Furthermore, the negative impact of fear of childbirth on birth self-efficacy makes the birthing experience more challenging for primiparous women. Key causes of fear of childbirth include intolerance to pain, concern about harming the mother or baby, fear of losing control during labor, and distrust of healthcare personnel. These fears are experienced more intensely, especially in women who have never given birth before; comparative studies have found that primiparous women have significantly higher levels of fear compared to multiparous women. Negative emotions experienced during childbirth directly affect a mother's comfort during labor, her satisfaction with the birth, and her postpartum well-being. Although pain is a natural part of childbirth, how this process is managed, the mother's overall perception of childbirth, and its duration play a decisive role. According to the World Health Organization, the global cesarean section rate is 21%, while in Türkiye this rate has reached 58% (Turkish Statistical Institute, 2023). This situation once again emphasizes the importance of managing the fear of childbirth and pain. In conclusion, it appears that yoga practices help reduce fear of childbirth, contribute to women developing a positive perception of childbirth, and increase satisfaction with birth.

02

Conditions studied

  • Primiparous Pregnant Women
  • Yoga
  • Labor Pains

Browse trials for

Keywords

  • Primiparous Pregnant Women
  • yoga
  • labor pain
03

In context

Labor Pain

423 studies on the registry are indexed under Labor Pain; 74 are open to participants now.

This study's planned enrollment of 74 is below the median of 100 across 347 interventional studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

This is the only study on the registry with Handan ASATEKİN as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volunteers to participate in the study,
  • Able to communicate in Turkish,
  • Literate,
  • Not diagnosed with any high-risk pregnancy,
  • Primiparous (first pregnancy),
  • In latent phase (dilation 0-5 cm) upon admission to the delivery room,
  • Not having a previous psychiatric diagnosis,
  • Pregnant women without any identified maternal or infant risk factors during their pregnancy.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women who give birth via cesarean section and do not meet the inclusion criteria will be excluded from the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
74 participants (estimated)

Study arms

  • Experimental
    innatal yoga group

    Primiparous pregnant women arriving at the hospital for delivery will be randomly divided into two groups after admission to the delivery room (latent phase) if they meet the sampling criteria. The pregnant women will be informed about the study and their consent obtained through face-to-face interviews conducted by the researchers. Pregnant women with cervical dilation between 0-5 cm who are randomly selected for the study will complete a Personal Information Form, the Numerical Rating Scale (MRS), the Verbal Category Scale (VCS), and the Birth Comfort Scale (BCS). The pregnant women will perform 8 different innatal yoga poses determined by the researchers, each pose lasting 5 minutes, for a total of 40 minutes. Following the yoga practice, a vaginal examination will be performed by the same midwife, and the MRS, VCS, and BCS will be administered again. After labor, the Birth Satisfaction Scale-Short Form (BSS-S) will be administered to the women.

    Other: innatal yoga group

  • No intervention
    routine primiparous group

    Primiparous pregnant women arriving at the hospital for delivery will be randomly assigned to two groups after admission to the delivery room (latent phase), provided they meet the sampling criteria. These women in the control group will be informed about the study and their consent obtained through face-to-face interviews conducted by the researcher. Pregnant women with cervical dilation between 0-5 cm who were assigned to the control group after randomization will complete the Personal Information Form, the Numerical Rating Scale (MRS), the Verbal Category Scale (VCS), and the Birth Comfort Scale (BCS). After receiving routine care, the same midwife will perform a vaginal examination on the pregnant woman 40 minutes later, and the MRS, VCS, and BCS will be administered again. Following labor, the Birth Satisfaction Scale-Short Form (BSS-S) will be administered to the pregnant women in the control group.

Interventions

  • Otherinnatal yoga group

    Primiparous pregnant women with cervical dilation between 0-5 cm, who were randomly assigned to experimental and control groups, will be administered a Personal Information Form, the Numerical Rating Scale (MRS), the Verbal Category Scale (VCS), and the Birth Comfort Scale (BCS). Following this, only the pregnant women in the experimental group will perform 8 different yoga poses, each pose lasting 5 minutes, as determined by the researchers. Routine care will be provided to the control group. After the yoga session, a vaginal examination will be performed by the same midwife, and all pregnant women will be re-administered the MRS, VCS, and BCS. After labor, both the experimental and control groups will be administered the Birth Satisfaction Scale-Short Form (BSS-S).

06

What researchers measure

Primary outcomes

  1. Yoga practices aim to reduce fear of childbirth, help women develop a positive perception of childbirth, and increase satisfaction with birth.

    The DMÖ-K is a 10-item scale using a five-point Likert type. The scale is scored as follows: "Strongly agree" (4 points), "Agree" (3 points), "Undecided" (2 points), "Disagree" (1 point), "Strongly disagree" (0 points). Items 2, 4, 7, and 8 are reverse-calculated. The lowest possible score is "0", and the highest is "40"; higher scores indicate higher satisfaction levels.

    Time frame: From the 0-5 cm cervical dilation range to the early postpartum period (4-24 hours)

07

Study locations

1 site
  • Mus Alparslan University Campus, Diyarbakir Road 7th km, 49250 Mus Center/Mus,
    Muş, Mus Center 49250, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2027, 12 months later.

Of 191 non-industry interventional studies with no phase under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 14. This study's planned 12 months is above that.

Counting every sponsor, half of 193 studies reached it within 9 months; a quarter within 5 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 6, 2026
First posted
Sep 24, 2026
StartEst.
Nov 15, 2026
Primary completionEst.
Dec 1, 2027
CompletionEst.
Dec 1, 2027
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07839962
Lead sponsor
Handan ASATEKİN
Responsible party
Handan ASATEKİN (research assistant, Muş Alparslan University) — Sponsor-investigator
First posted
Sep 24, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Dec 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Sep 24, 2026

Study contacts

Handan ASATEKİN YAZGU, PhD
Contact
h.asatekin@alparslan.edu.tr
+90 507-181-3511

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion